C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 110 filers reported holding C4 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,172 | -88.1% | 30,200 | -82.4% | 0.00% | -100.0% |
| Q2 2023 | $471,900 | +7.0% | 171,600 | +22.2% | 0.00% | 0.0% |
| Q1 2023 | $440,956 | -44.5% | 140,432 | +4.3% | 0.00% | -66.7% |
| Q4 2022 | $794,577 | -18.8% | 134,674 | +20.7% | 0.00% | 0.0% |
| Q3 2022 | $978,000 | +22.4% | 111,556 | +5.3% | 0.00% | +50.0% |
| Q2 2022 | $799,000 | -26.0% | 105,929 | +138.0% | 0.00% | 0.0% |
| Q1 2022 | $1,080,000 | -24.6% | 44,500 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,433,000 | -27.9% | 44,500 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $1,988,000 | +18.1% | 44,500 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $1,684,000 | – | 44,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |